GF Fund Management’s AstraZeneca AZN Stock Holding History

GF Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,299	Closed	-$12.4M	–	627
2025 Q4	$12.4M	Buy	67,299 +2,378	+4%	+$417K	0.21%	81
2025 Q3	$9.96M	Sell	64,921 -1,885	-3%	-$285K	0.18%	102
2025 Q2	$9.34M	Buy	66,806 +3,127	+5%	+$438K	0.19%	101
2025 Q1	$9.36M	Buy	63,679 +2,386	+4%	+$345K	0.22%	88
2024 Q4	$8.03M	Buy	+61,293	New	+$8.58M	0.17%	99

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

GF Fund Management's AZN Position: Q1 2026 in Review

GF Fund Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 67,299 shares — an estimated $12.4M sold.

GF Fund Management first reported a position in AZN in Q4 2024 and held it in 5 quarters. The position peaked at $12.4M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

GF Fund Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
GF Fund Management sold 67,299 AstraZeneca shares in Q1 2026, an estimated $12.4M.
GF Fund Management first reported a position in AstraZeneca in Q4 2024 and held it in 5 quarters.
GF Fund Management's AstraZeneca position peaked at $12.4M in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.